Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00087945 · ClinicalTrials.gov registry record · NA
Blood Levels of Abacavir in HIV Infected Adolescents
A NA study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT00087945 is a NA study that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 30 participants.
The verdict
NCT00087945, a NA study, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The way abacavir (ABC) behaves in the body differs between children and adults, but little is known about ABC in adolescents. It is unclear if adult doses of ABC are appropriate for adolescents. The purpose of this study is to determine the blood levels of ABC in HIV infected adolescents who are on ABC-containing regimens.
Interventions
- DRUG Abacavir sulfate
- DRUG Abacavir sulfate, lamivudine, and zidovudine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2004-07 |
| Est. Completion | 2004-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00087945
The ClinicalTrials.gov registry entry for NCT00087945 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Abacavir sulfate is the first listed.
NCT00087945 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00087945 about?
NCT00087945 is a clinical study titled "Blood Levels of Abacavir in HIV Infected Adolescents". The way abacavir (ABC) behaves in the body differs between children and adults, but little is known about ABC in adolescents. It is unclear if adult doses of ABC are appropriate for adolescents. The purpose of this study is to determine the blood levels of ABC in HIV infected adolescents who are on ...
What is the current status of trial NCT00087945?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2004-07. Estimated completion is 2004-12.
What interventions are being tested in trial NCT00087945?
The interventions under investigation include: Abacavir sulfate (DRUG), Abacavir sulfate, lamivudine, and zidovudine (DRUG).
Who is sponsoring clinical trial NCT00087945?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.